Partner with MoleculeDx to offer your at-risk patients best-in-class HCC surveillance without adding clinical burden.
Our provider program integrates seamlessly with existing clinical workflows. Order tests, track results, and receive actionable alerts — all within your existing systems.
Order MoleculeDx tests directly from your EHR via HL7/FHIR integration or our lightweight web portal. CPT coding and billing support included.
Results are delivered directly to your preferred EHR system within 24 hours. Flags and abnormal results trigger real-time provider alerts via your preferred channel.
We handle all patient communication, scheduling, and home visit logistics. Your team only needs to order the test — we manage the rest.
Track screening compliance across your entire at-risk patient panel. Identify gaps, set reminders, and report on program performance — all in one dashboard.
As our flagship clinical partner, UPMC has developed a full integration protocol for the MoleculeDx test. We work with UPMC’s oncology team on all positive result referrals.
Our billing team handles prior authorization, insurance verification, and appeals for denied claims. We maximize reimbursement so your patients face minimal out-of-pocket cost.
UPMC physicians can order the test via the UPMC Epic integration, or patients can self-refer by walking in to any UPMC facility and requesting the MoleculeDx liver cancer screen.
At UPMC sites with phlebotomy services, the blood draw is performed on-site. For patients who prefer at-home collection, Portamedic or Travalab is dispatched to their address.
Results are returned within 24 hours directly to the patient’s UPMC Epic record. Abnormal results trigger automatic alerts to the ordering physician and UPMC Hepatology.
Ready to set up MoleculeDx in your practice or health system? Our clinical partnerships team can have you onboarded in under a week.
You may benefit from regular liver cancer screening if you have one or more of these conditions.
Hospitals and clinics can apply through the For Providers page or write to partners@moleculedx.com. Once verified, your facility is onboarded into the Moleculedx partner network with its own secure portal, doctor list and pricing configuration.
The Moleculedx Doctor Partnership Programme is for referring physicians and specialists. Enrolled doctors can refer patients for testing, access patient reports (with consent), and receive the benefits of being part of our medical advisory and incentive network.
Eligible doctors who actively refer patients to Moleculedx are part of our incentive programme. Specific incentive structures, eligibility and payout terms are shared on a case-by-case basis during onboarding and governed by a written agreement.
On successful onboarding, your facility receives a dedicated, secure login to the relevant portal — the Hospital Portal for hospitals and the Lab Portal for partner labs. Each portal lets you create walk-in bookings, manage doctors, view bookings, and configure pricing.
Yes. Each partner hospital and partner lab can have a custom price list per test, configured by the Moleculedx team. The right price is automatically applied during walk-in bookings made through your portal.
Turnaround time depends on the test panel — typically 5 to 10 working days from sample receipt. Exact turnaround for each test is shown in the portal and on the patient’s confirmation, so your front desk can set accurate expectations.
If the patient is booked with a referring doctor or under your facility, the report is made available to the authorising doctor and to the hospital portal — subject to applicable consent and data-privacy rules.
Yes. On onboarding, Moleculedx provides a portal walkthrough, a written user manual for hospital and lab staff, and a designated point-of-contact at Moleculedx for go-live support and any subsequent escalations.
Data flows over secure, encrypted channels. Your portal provides a unified view of online and walk-in bookings linked to your facility, with role-based access so each staff member only sees what they’re authorised to see. Audit logs track every access and change.
Each partner has a designated Moleculedx contact for clinical queries (sample issues, repeat testing, report clarifications) and a separate operations contact for portal, billing or scheduling issues. SLAs and response timelines are agreed during onboarding.
First-in-class blood-based liver cancer early detection. Powered by Fusion-detect™ AI genomics technology.
© 2026 MoleculeDx Inc. All rights reserved.
This test is not a substitute for medical diagnosis. Consult your physician with all results.